Skip to main content
RENALYTIX PLC logo

RENALYTIX PLC — Investor Relations & Filings

Ticker · RENX ISIN · GB00BYWL4Y04 LEI · 213800NTOH3FK3WER551 IL Human health and social work activities
Open in API
Filings indexed 445 across all filing types
Latest filing 2022-01-27 Remuneration Information
Country GB United Kingdom
Listing IL RENX

About RENALYTIX PLC

https://renalytix.com/

Renalytix is a diagnostics company that develops artificial intelligence-enabled solutions for the clinical management of kidney disease. Its flagship product, KidneyIntelX.dkd™, is an FDA-authorized blood test for adults with type 2 diabetes and early-stage chronic kidney disease. The test utilizes a proprietary bioprognostic™ methodology to analyze biomarkers and clinical data, predicting the risk of a progressive decline in kidney function over a five-year period. This risk assessment enables clinicians to identify high-risk patients and implement targeted, guideline-recommended treatments to slow disease progression and improve outcomes.

Recent filings

Filing Released Lang Actions
Grant of Share Options
Remuneration Information Classification · 99% confidence The document is a regulatory announcement identified by the 'RNS Number' and the closing statement referencing RNS and the London Stock Exchange. The content explicitly details the 'Grant of Share Options' to a 'Non-Executive Director' (Daniel Levangie) and includes structured tables detailing the transaction (price, volume, date). This type of filing, reporting personal share transactions by company directors/executives, directly corresponds to the definition of Director's Dealing (DIRS). It is not a general regulatory filing (RNS) because it fits a more specific category, nor is it a remuneration report (DEF 14A) as it concerns specific option grants to an individual, not overall compensation policy.
2022-01-27 English
Conference attendance
Regulatory Filings Classification · 99% confidence The document is identified by the RNS Number (7789Z) and the date (27 January 2022). The content announces that Renalytix plc will be presenting at an upcoming conference (BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference) and provides details about the management participation (fireside chat). This is a general announcement regarding corporate activity, specifically investor relations engagement, rather than a core financial report (like 10-K, IR, ER) or a specific regulatory filing like a Director's Dealing or Dividend Notice. Since it is a general announcement distributed via the RNS system, and it doesn't fit the specific categories like AGM-R, ER, or DIV, the most appropriate classification is the general regulatory announcement category, RNS, as it is a standard market communication.
2022-01-27 English
Positive Study Results Published for KidneyIntelX
Regulatory Filings Classification · 98% confidence The document begins with an RNS Number and date, indicating a regulatory announcement format typical of the London Stock Exchange. The content is a press release announcing that positive study results for 'KidneyIntelXTM' have been published in 'The American Journal of Nephrology'. This is not the full study report itself, nor is it a comprehensive financial report (like 10-K or IR). It is an announcement about external scientific validation and publication. Since it is a formal announcement disseminated via RNS (Regulatory News Service), and it doesn't fit the specific categories like Earnings Release (ER), Management Discussion (MDA), or Capital Update (CAP), the most appropriate classification is the general regulatory announcement category, RNS, as it serves to disseminate material, non-financial news to the market.
2022-01-11 English
Partnership with Singing River for KidneyIntelX
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 8490X' and contains standard boilerplate language at the end referencing 'RNS, the news service of the London Stock Exchange' and the 'Financial Conduct Authority'. The content itself is a press release announcing a partnership between Renalytix and Singing River Health System regarding the deployment of KidneyIntelX technology. This format—a brief announcement of a significant business event, distributed via an official regulatory news service (RNS)—is characteristic of a general regulatory announcement that doesn't fit the more specific categories like 10-K, ER, or DIV. Since it is a formal announcement distributed through the RNS system and serves as a general regulatory update, the most appropriate classification is Regulatory Filings (RNS). The document length (12,405 chars) is substantial enough that it is not merely an RPA, but a full announcement.
2022-01-10 English
Appointment of Jean M. Casner as CHRO
Board/Management Information Classification · 98% confidence The document is identified by the RNS Number header and contains a press release format announcing a significant personnel change: the appointment of a new Chief Human Resources Officer. This type of announcement, detailing changes in senior management, directly corresponds to the 'Board/Management Information' category. Although it is distributed via RNS, the core content is management-related, making MANG the most specific classification over the general RNS fallback.
2022-01-07 English
RENX to present at 40th JP Morgan Healthcare Conf.
Regulatory Filings Classification · 100% confidence The document is a short announcement (3780 characters) released via RNS (Renalytix PLC, RNS Number : 4318X) on January 5, 2022. The core content states that the company 'will be presenting at the upcoming 40th Annual J.P. Morgan Virtual Healthcare Conference' on January 12, 2022, and provides a link to the webcast. This is not the presentation itself, but an announcement about a future presentation event. This fits the definition of a general regulatory announcement or news release that doesn't fit a more specific category like ER, DIV, or CAP. Since it is a general announcement distributed via the RNS system, and it is not a full report, the most appropriate classification is Regulatory Filings (RNS), as it serves as a general notification to the market about a corporate event (a conference presentation). It is not an Investor Presentation (IP) because it only announces the presentation, it is not the presentation material itself.
2022-01-05 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.